QBNK acquires global pharmaceutical client

Customer Case | Press Release

QBNK has signed with one of the world's largest pharmaceutical companies who will use QBank as a platform for managing images, movies and other marketing material on the nordic market.

The platform QBank continues its succesful development. The contract gives us a vital client with in the pharmaceutical business. We now have the possibility to establish ourselves in an entirely new segment where we assess there is a great need for our platform. Pharmaceutical organizations are often global with limited marketing communications to manage with retailers and consumers. With QBank as a platform, organizations can see a positive result in a short period of time as well as quickly gained client revenue, says Carl Petruson, CEO.

The initial value of this contract is currently valued at half a million SEK. More information about this contract and what it will mean for QBNK will be presented later on this spring.


About QBNK Holding AB (publ)

QBank's mission is to provide companies and government agencies cloud-based products and services in Digital Asset Management. The company is growing at 30-40% per year.

The ticker symbol for the stock is: QBNK
ISIN code of the company's shares is: SE0007278726

For more information, please contact:

Carl Petruson, CEO
QBNK Holding AB (publ)
Tel: +46 8-459 99 90
e-mail: carl.petruson@qbank.se

Download PDF Download Press Release (Swedish)

Subscribe now

Don't miss the latest news from QBank.

Start your journey today

Book a demo with our sales team